Cloning and sequencing of the cDNA encoding Pneumocystis carinii inosine monophosphate dehydrogenase (IMPDH). NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Cloning and sequencing of the cDNA encoding Pneumocystis carinii inosine monophosphate dehydrogenase (IMPDH).

Abstr Gen Meet Am Soc Microbiol. 1994;94:590 (abstract no. F-13). Unique Identifier : AIDSLINE ASM94/94313113
O'Gara MJ; Queener SF; Lee CH; Indiana University School of Medicine, Indianapolis.


Abstract: Pneumocystis carinii is an opportunistic pathogen that causes pneumonia in immunocompromised hosts. Chemotherapy is available for treating P. carinii pneumonia, but severe toxicity is a significant problem with the compounds currently considered drugs of choice. IMP dehydrogenase (IMPDH; EC 1.1.1.205) may be a good alternative target for anti-Pneumocystis chemotherapy because IMPDH inhibitors have been used successfully to treat leukemia. Our lab found the IMPDH inhibitor, mycophenolic acid, to be effective in preventing the growth of P. carinii in culture. In order to characterize P. carinii IMPDH and assay potential inhibitors in vitro, we cloned part of the IMPDH gene. Initially, we amplified a 1.3 kb fragment of P. carinii IMPDH from genomic DNA using PCR and two degenerate oligonucleotides based on two conserved sequences identified in IMPDH from six different species. The DNA sequence of the 1.3 kb product indicated the presence of putative introns having the characteristic 5'-GT and AG-3' signal. Using a combination of RACE (rapid amplification of cDNA ends) and RT-PCR, we isolated and cloned the entire cDNA of the P. carinii IMPDH. The nucleotide and amino acid sequences (57-59% and 32-63%, respectively) revealed significant homology with published sequences of IMPDH genes. We are currently working to express P. carinii IMPDH which will be assayed to confirm catalytic activity.
Keywords: Amino Acid Sequence Base Sequence Cloning, Molecular/*METHODS Comparative Study DNA, Complementary/*ANALYSIS DNA, Fungal/ANALYSIS/GENETICS Gene Amplification IMP Dehydrogenase/*GENETICS Pneumocystis carinii/*ENZYMOLOGY/*GENETICS Polymerase Chain Reaction/METHODS Sequence Homology, Amino Acid Sequence Homology, Nucleic Acid ABSTRACTKWDaminoacidsequencebasesequencecloning,molecular/KWDmethodscomparativestudydna,complementary/KWDanalysisdna,fungal/analysis/geneticsgeneamplificationimpdehydrogenase/KWDgeneticspneumocystiscarinii/KWDenzymology/KWDgeneticspolymerasechainreaction/methodssequencehomology,aminoacidsequencehomology,nucleicacidabstract
941030
M94A0841

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .